Larry Ellison Cancels $7.5B Oracle Stock Sale Amid AI Pivot and Regulatory Scrutiny

Oracle co‑founder, chairman and CTO Larry Ellison filed a Rule 10b5‑1 trading plan on June 22 that would have allowed him to sell up to 50 million shares — valued at roughly $8.75 billion at the time of filing, but about $7.5 billion after the stock fell ~16 % — with the plan set to expire on October 24.

The 10b5‑1 mechanism lets corporate insiders pre‑set sale conditions to avoid insider‑trading liability. However, the plan’s timing clashed with the EU Market Abuse Regulation (MAR), which imposes a 30‑day blackout before earnings releases; under MAR such a pre‑arranged, later‑executed sale would be prohibited.

During the same week the plan became public, Oracle disclosed a gross‑margin decline and raised its restructuring‑cost estimate to $2.8 billion. The combined effect pressured the share price, which fell 1.74 % in regular trading and continued lower after hours.

On September 13 Oracle announced that Ellison had terminated the 10b5‑1 plan, confirming that no shares had been sold and that he had no other sale plans. The 82‑year‑old still holds nearly 40 % of Oracle and had not reduced his stake in the prior 15 years.

Ellison has been steering Oracle from a legacy software vendor into an AI infrastructure leader. The latest quarter showed cloud‑infrastructure revenue surging 121 % year‑over‑year, but the transformation has required heavy borrowing, contributing to a ~20 % share‑price decline year‑to‑date.

Ellison also faces large personal capital demands: he guaranteed $40 billion of equity financing for his son David’s Skydance‑Paramount merger and the proposed $110 billion acquisition of Warner Bros. Discovery.

Analysts view the 10b5‑1 filing as a routine diversification hedge for a concentrated holding, while the withdrawal signals confidence during a critical investment phase.

Glossary 10b5‑1 plan: An SEC rule allowing insiders to pre‑establish trade parameters so that subsequent automatic executions are not deemed to be based on material non‑public information. EU Market Abuse Regulation (MAR): EU legislation that bars corporate insiders from trading during the 30 calendar days preceding interim or annual financial reports.